Recent Updates
Recently added Catalysts
NKTX Positive Sentiment Score: 65/100

Nkarta to Participate in an Upcoming Investor Conference

Key Takeaway: Nkarta, Inc. (Nasdaq: NKTX), a company focused on developing engineered natural killer (NK) cell therapies, will participate in the 7th Annual Evercore HealthCONx Conference. The event will feature a fireside chat at 2:10 p.m. ET, with a simultaneous webcast available for viewers. Nkarta's advancements include allogeneic, off-the-shelf therapies that utilize a proprietary cell engineering platform and CRISPR technology. This participation reflects the company's ongoing commitment to expanding its therapeutic pipeline.

Market Sentiment Analysis

POSITIVE FACTORS

  • Nkarta is participating in a notable investor conference, indicating growing interest.
  • The company's focus on engineered NK cell therapies showcases innovative development.
  • Webcast availability enhances accessibility for investors.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
7th Annual Evercore HealthCONx Conference
2:10 p.m. ET – fireside chat
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:

Frequently Asked Questions

What conference is Nkarta participating in?

Nkarta is participating in the 7th Annual Evercore HealthCONx Conference.

When is Nkarta's fireside chat scheduled?

The fireside chat is scheduled for 2:10 p.m. ET.

Where can I watch the Nkarta webcast?

The webcast will be available on Nkarta's Investors section of their website.

How long will the webcast replay be available?

The replay will be archived for approximately 90 days.

What type of therapies does Nkarta develop?

Nkarta develops engineered natural killer (NK) cell therapies.

Last updated: Nov 26, 2024